Lupin gets USFDA nod for atopic dermatitis treatment lotion

Drug major Lupin today said it has received final approval from the United States Food and Drug Administration (USFDA) to market Hydrocortisone Butyrate lotion, used for the treatment of mild atopic dermatitis in patients 3 months of age and older, in the US market.

For Real Time News & Trading Trends Keep Liking Epic Research Limited

Facebook

Twitter

YouTube

Pinterest

Linkedin

Google+

Share Button

About the Author

Epic Research
Epic Research
Epic Research - Investment Adviser is a leading financial services provider with presence in Indian and other global capital markets. Call on - 0731-664-2300